The study, which surveyed more than 1,000 people across the United States, Mexico, and Brazil showed that consumers are prioritizing scientific literature and clinical trials to determine product effectiveness when choosing dietary supplements for immune health.
The consulting agency SPRIM Global announced the results of a study examining the connection between COVID-19 and the changes in consumer’s dietary supplement purchasing behavior. The study, which surveyed more than 1,000 people across the United States, Mexico, and Brazil showed that consumers are prioritizing scientific literature and clinical trials to determine product effectiveness when choosing dietary supplements for immune health.
The study also found that 61% of global consumers who have purchased dietary supplements in the last 12 months either began or increased their purchasing for immune health supplements during the pandemic. Fifty-seven percent of consumers also claim to be concerned about their immunity due to the pandemic, and 83% say they take immune support supplements every day and buy more when they run out. When it comes to specific supplements they are buying, vitamin C is the mainstay immune health ingredient they look for, with vitamin D coming in second due to studies demonstrating the correlation between low vitamin D levels and higher risk of contracting a serious case of COVID-19.
“We’re seeing a shift in consumers’ priorities,” said Susan Dallabrida, PhD, vice president of consultancy at SPRIM Global. “While healthcare practitioner endorsement can be influential, U.S. consumers strongly prefer to also see scientific evidence and clinical research that substantiate a product’s efficacy, allowing them to evaluate that product on its own merit.”
Samir Behl, management consultant and former regional president of Europe, India, and Africa at Amway, supports Dallabrida’s assertion. “This study highlights the importance of providing concrete evidence on the health benefits of supplements for consumers who are increasingly wary of questionable claims promising curative or prophylactic benefits,” said Behl. “For a supplement brand to be successful long term, it's essential that credible information be provided to consumers, as well as to healthcare providers, in order to get their support or endorsement. Scientific data using the correct testing protocol to support product efficacy is essential in this regard.”
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.
Survey finds a lack of enthusiasm about AI technology among food and beverage consumers
December 12th 2024The survey, commissioned by Ingredient Communications and conducted by SurveyGoo, found that 83% of respondent agreed that companies should declare on product labels when a product has been designed or manufactured with the assistance of AI technology.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.